Clarify Health
From AltData.wiki, The Alternative Data Encyclopedia
Clarify Health is a United States healthcare-analytics company that develops software and data products for evaluating care delivery, quality, cost, and provider-network performance. Its current flagship platform, Clarify Meridian, is aimed at health systems and combines referral intelligence, quality measures, physician and patient engagement, and attribution of outcomes.[1][2]
CB Insights identifies the company as founded in 2015 and based in San Francisco, and describes its customers as healthcare providers, payers, technology and services organizations, and life-sciences companies.[3] Clarify's current website places particular emphasis on referral completion and network retention. It says that Meridian is built on the Clarify Atlas data platform and is delivered with services whose commercial incentives are tied to measured results.[1]
What It Does
Meridian is designed to help a health system examine where referred patients receive care, compare specialist performance, assess whether an in-network provider has suitable capacity, and estimate the financial consequences of changing referral pathways.[1][2] The intended workflow extends from identifying an opportunity through physician or patient engagement to measuring subsequent utilization and outcomes.[2]
The platform addresses operational and financial questions rather than providing clinical care. The public materials describe analysis and activation around referrals, networks, payment models, and care pathways; they do not state that the software replaces clinician judgment or guarantees that a referral will be completed.[1][2]
Data and Methodology
Clarify says that the Atlas foundation contains longitudinal records representing more than 300 million patient lives across care settings, 5.6 trillion negotiated price-transparency rates, models for more than 70 fee-for-service and value-based payment arrangements, and over 20 billion machine-learning predictions.[1] These are company-reported figures; no independent audit of the counts was identified in the sources reviewed.[1]
The described outputs include estimates of quality, cost, care pathways, referral leakage, site of service, and network performance.[1][2] Because such measures depend on record linkage, coding, attribution rules, and model assumptions, buyers need product-level documentation on data provenance, refresh schedules, missingness, validation, privacy controls, and the definitions used for outcomes. Those details are not fully disclosed on the public overview pages.[1][2]
Products and Delivery
The current product structure centers on Meridian, with functions called Survey, Plan, and Guide.[2] The company presents the software together with dedicated success-services personnel working with health-system operations, rather than as a self-service public database.[1] Public list pricing is not shown; prospective customers are directed to request a briefing.[1][2]
Clarify announced an acquisition of Loyal Health in June 2026 to combine network intelligence with patient activation.[4] The transaction was also listed in CB Insights' company news feed.[3] The reviewed sources establish the announcement, but they do not provide public transaction terms or independently measure whether the combined platform improves clinical or financial outcomes.[3][4]
Buyers and Use Cases
The present website is directed primarily at health systems seeking to analyze referral leakage, specialist networks, care quality, capacity, site-of-service choices, and performance under alternative payment models.[1][2] Clarify states that it works with more than 60 health systems and reports $3.2 billion in documented customer return on investment; both figures are vendor claims and should be interpreted according to the company's measurement definitions.[1]
Independent company profiling describes a historically broader customer set that also includes payers, life-sciences companies, and healthcare technology and services organizations.[3] Appropriate uses may therefore vary by contract and product generation. The public sources do not disclose a customer-level dataset inventory, accuracy benchmark, or standardized outcome study covering all deployments.[1][3]